Mobile

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the safety, preliminary clinical activity and immunogenicity of multiple doses of MOR103 administered intravenously to pat...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-006129-29

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the safety, preliminary clinical activity and immunogenicity of multiple doses of MOR103 administered intravenously to patients with active rheumatoid arthritis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Safety and tolerability of multiple doses of MOR103 in patients with active rheumatoid arthritis.

Critère d'inclusion

  • Rheumatoid Arthritis

Liens